Announcements
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
- EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
- EQS-DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
- EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
- EQS-News: Investor interest returns – dividend yield remains high for 2024
More ▼
Key statistics
On Thursday, BB Biotech AG (BBZA:FRA) closed at 41.45, 12.94% above the 52 week low of 36.70 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.80 |
---|---|
High | 42.80 |
Low | 40.95 |
Bid | 40.85 |
Offer | 41.50 |
Previous close | 41.45 |
Average volume | 4.42k |
---|---|
Shares outstanding | 55.40m |
Free float | 54.42m |
P/E (TTM) | -- |
Market cap | 2.30bn CHF |
EPS (TTM) | -3.76 CHF |
Annual div (ADY) | 2.05 EUR |
---|---|
Annual div yield (ADY) | 4.86% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 15 minutes, as of Apr 25 2024 20:57 BST.
More ▼